Product Details
Product Name:
Fexinidazole |
CAS No.:
59729-37-2 |
Purity:
99.79% |
Supply Ability:
10g |
Release date:
2024/11/16 |
Product Introduction
Bioactivity
名稱 | Fexinidazole |
描述 | Fexinidazole (HOE 239) is an antiparasitic agent with activity against Trypanosoma cruzi, Tritrichomonas foetus, Trichomonas vaginalis, Entamoeba histolytica, Trypanosoma brucei, and Leishmania donovani. The biologically relevant active metabolites in vivo are the sulfoxide and sulfone. |
激酶實驗 | Promoter-luciferase reporter assay: A 2,767-bp sequence of human survivin gene promoter is isolated from human genomic DNA by PCR using Pyrobest polymerase and the following primers: 5 |
存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 50 mg/mL (179.01 mM)
|
關鍵字 | antitrypanosomal | nitroimidazole | sleeping | T.brucei | Fexinidazole | sickness | orally | HOE-239 | Inhibitor | inhibit | HAT | HOE239 | Parasite |
相關產(chǎn)品 | Hydroxychloroquine | Doxycycline |
相關庫 | 抗寄生蟲庫 | 經(jīng)典已知活性庫 | 藥物功能重定位化合物庫 | FDA 上市藥物庫 | 已知活性化合物庫 | 抗感染化合物庫 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:1228690-36-5
$33.00 / 1mg
-
CAS:62687-63-2
$50.00 / 1mg
-
CAS:17348-76-4
$50.00 / 100mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$250.60/1KG |
VIP4Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-21 |